Univariate Analysis of Putative Risk Factors for CLD in 117 Anti-HCV+ Patients
| . | . | Patients With CLD . | Patients With Normal ALT Levels . | P Level . |
|---|---|---|---|---|
| No. of patients | 92 (76.6%) | 25 (21.4%) | ||
| Sex | Male | 58 (63%) | 12 (48%) | >1 |
| Female | 43 (37%) | 13 (52%) | ||
| Age at diagnosis (in yr) | Mean | 5.7 | 5.7 | |
| Median | 4.9 | 4.9 | >.1 | |
| Range | 0.3-19.7 | 0.6-17 | ||
| Follow-up duration | Mean | 14.5 | 13.4 | |
| Median | 14.2 | 13.4 | >.1 | |
| Range | 5,1-24,8 | 5.9-20 | ||
| Diagnosis | L/L | 55 (59.8%) | 19 (76%) | >.1 |
| ST | 37 (40.2%) | 6 (24%) | ||
| Blood transfusions, no. of patients | Yes | 70 (76%) | 21 (84%) | >.1 |
| No | 22 (34%) | 4 (16%) | ||
| No. of transfused blood units | Mean | 8 | 8 | |
| Median | 4 | 4 | >.1 | |
| Range | 0-43 | 0-38 | ||
| No. of HBV+ patients | 17 (18.4%) | 3 (12%) | >1 | |
| No. of HDV+ patients | 9 (10%) | 0 | .1 |
| . | . | Patients With CLD . | Patients With Normal ALT Levels . | P Level . |
|---|---|---|---|---|
| No. of patients | 92 (76.6%) | 25 (21.4%) | ||
| Sex | Male | 58 (63%) | 12 (48%) | >1 |
| Female | 43 (37%) | 13 (52%) | ||
| Age at diagnosis (in yr) | Mean | 5.7 | 5.7 | |
| Median | 4.9 | 4.9 | >.1 | |
| Range | 0.3-19.7 | 0.6-17 | ||
| Follow-up duration | Mean | 14.5 | 13.4 | |
| Median | 14.2 | 13.4 | >.1 | |
| Range | 5,1-24,8 | 5.9-20 | ||
| Diagnosis | L/L | 55 (59.8%) | 19 (76%) | >.1 |
| ST | 37 (40.2%) | 6 (24%) | ||
| Blood transfusions, no. of patients | Yes | 70 (76%) | 21 (84%) | >.1 |
| No | 22 (34%) | 4 (16%) | ||
| No. of transfused blood units | Mean | 8 | 8 | |
| Median | 4 | 4 | >.1 | |
| Range | 0-43 | 0-38 | ||
| No. of HBV+ patients | 17 (18.4%) | 3 (12%) | >1 | |
| No. of HDV+ patients | 9 (10%) | 0 | .1 |